The post Zoe Brooks leads the way as No. 13 NC State’s guards supplant No. 1 Notre Dame, its highly-touted backcourt duo appeared first on On3.

A $4.75m grant will support the development of EIS-12656, which is being studied alone and in combination with PARP inhibitors.

AstraZeneca has thrown down the gauntlet to AbbVie and Johnson & Johnson with new data for Calquence in chronic lymphocytic leukaemia (CLL) that it says show a safety advantage over Imbruvica ...